About
Drug Formulation Technologies
Areas of Focus
Categories
Drug Delivery & FormulationMidwest
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
73
By Phase
PHASE1: 1EARLY_PHASE1: 1PHASE2: 1
By Status
UNKNOWN: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05864885Lead Sponsor
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
PHASE1Unknown
14 participants
Started: Jun 9, 2023 · Completed: Jul 17, 2023
NCT05790941Lead Sponsor
Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation
EARLY_PHASE1Unknown
12 participants
Started: Mar 11, 2023 · Completed: Jun 30, 2023
NCT01977443Lead Sponsor
Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)
PHASE2Completed
47 participants
Started: Nov 30, 2013 · Completed: Sep 30, 2016
Locations (1)
Headquarters
St. Louis, MO, United States
Map
Loading map...